Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Aptose Bioscns

(NASDAQ: APTO)
Add to Portfolio
+0.05 (+0.87%)
as of Apr 3, 2020

Last 5.80
Change +0.05 (+0.87%)
Open 5.71
Prev. Close 5.75
Today's Range
5.57
5.94
52wk Range
1.81
9.25
Volume 457000
Avg Volume 970775
Sector SIC-2836 Biological Products, (No Disgnostic Substanc

Perfomance Comparison

Name Today 3-Month 1-Year
APTO +0.87% -6.90% +197.44%
DJIA -1.69% -27.80% -19.70%
S&P 500 -1.51% -25.17% -13.39%

Key Statistics

Annual EPS -0.52
Dividend Yield 0.00%
P/E Ratio N/A
Market Capitalization, $K 438490
Weighted Alpha +164.90
Standard Deviation +0.11
Profit Margin N/A
Beta 1.77

Growth Rates

YTD +2.29%
1-Year +198.97%
3-Year +480.00%
5-Year -8.37%
10-Year -82.79%

Opinion

Sell Hold Buy

Recent Headlines

Aptose Reports Results for the Fourth Quarter and Full

GlobeNewswire via COMTEX - Tue Mar 10, 04:02PM EDT
Aptose Biosciences Inc. ("Aptose" or the "Company") (NASDAQ: APTO, TSX: APS), a clinical-stage company developing highly differentiated agents that target the underlying mechanisms of cancer, today announced financial results for (full story)
APTO: 5.80 (+0.05)

Aptose Biosciences, Inc. to Host Earnings Call

ACCESSWIRE via COMTEX - Tue Mar 10, 03:00PM EDT
NEW YORK, NY / ACCESSWIRE / March 10, 2020 / Aptose Biosciences, Inc. (NASDAQ:APTO) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on March 10, 2020 at 5:00 PM Eastern Time.(full story)
APTO: 5.80 (+0.05)

Aptose to Release Fourth Quarter and Year End December

GlobeNewswire via COMTEX - Tue Feb 25, 07:31AM EST
Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage company developing highly differentiated therapeutics that target the underlying mechanisms of cancer, will release its financial results for the quarter and year (full story)
APTO: 5.80 (+0.05)

Aptose Biosciences to Host Key Opinion Leader Event

GlobeNewswire via COMTEX - Wed Jan 29, 07:30AM EST
Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage company developing highly differentiated therapeutics that target the underlying mechanisms of cancer, today announced that the company will host a key opinion lea(full story)
APTO: 5.80 (+0.05)

Aptose Biosciences to Present at Biotech Showcase(TM)

GlobeNewswire via COMTEX - Tue Jan 07, 07:30AM EST
Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage company developing highly differentiated therapeutics that target the underlying mechanisms of cancer, today announced that William G. Rice, Ph.D., Chairman, Presi(full story)
APTO: 5.80 (+0.05)